LaithIsmail MahmoudAbushahinMD

Oncology • Columbus, OH

Assistant Professor, Internal Medicine, Ohio State University. The James Comprehensive Cancer Center.

Join to view full profile

Dr. Abushahin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abushahin's full profile

Already have an account?

Office
2050 Kenny Rd
8th Floor Tower
Columbus, OH 43221
Phone+1 614-293-6529

Fax+1 614-293-6496

Education & Training

Baylor University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2013
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2008 - 2011
University of Jordan Faculty of MedicineClass of 2006

Certifications & Licensure

TX State Medical License 2022 - 2024
OH State Medical License 2018 - 2023
IA State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers Start of enrollment: 2015 Apr 01
Completed
Phase 3
A Study of Durvalumab (MEDI4736) in Esophageal Cancer Start of enrollment: 2016 Apr 27
Completed
Phase 2
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma Start of enrollment: 2016 Dec 05
Completed
Phase 1
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Start of enrollment: 2020 Jun 24
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

97 citations
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Adithya Chennamadhavuni, Laith Abushahin, Ning Jin, Carolyn J Presley, Ashish Manne
Frontiers in Immunology. 2022-01-01
29 citations
Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resec...
Adam R. Wolfe, Dhivya Prabhakar, Vedat O. Yildiz, Jordan M. Cloyd, Mary Dillhoff
Cancer Medicine. 2020-07-01
18 citations
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Re...
Hirva Mamdani, Bryan J. Schneider, Susan M. Perkins, Heather Burney, Pashtoon Murtaza Kasi
Frontiers in Oncology. 2021-09-17

Press Mentions

Rep. John Lewis and Alex Trebek Have Pancreatic Cancer. What Are Symptoms, Treatments?December 30th, 2019

Grant Support

Pipeline for Accelerated Cancer TherapueticsHolden Comprehensive Cancer Center2016–Present

Committees

Board of Directors, Alliance for Clinical Trials in Oncology 2016 - Present
Principal Investigator, Alliance of Clinical Trials of Oncology 2016 - Present
Member, Data Safety and Monitoring Committee 2016 - Present
Member, Clinical Competency Committee 2014 - Present
Member, Tissue Procurement Core Utelization Committee 2014 - Present
Member, Big Ten Cancer Research Consortium GI Subcomittee 2014 - Present